参考文献/References:
[1] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018,68(6):394-424.
[2] Randrian V,Evrard C,Tougeron D.Microsatellite instability in colorectal cancers:Carcinogenesis,neo-antigens,immuno-resistance and emerging therapies[J].Cancers(Basel),2021,13(12):3063.
[3] Vodenkova S,Buchler T,Cervena K,et al.5-fluorouracil and other fluoropyrimidines in colorectal cancer:Past,present and future[J].Pharmacol Ther,2020,206:107447.
[4] 张 慧,陈景志,陈建立,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义[J].陕西医学杂志,2019,48(8):968-971.
[5] 史 璇,张 鑫,朱金朋,等.结直肠腺癌组织中CYR61和血管内皮生长因子的表达及相关性研究[J].陕西医学杂志,2019,48(4):421-423.
[6] Paco A,Aparecida DE,Bessa-Garcia S,et al.Roles of the HOX proteins in cancer invasion and metastasis[J].Cancers(Basel),2020,13(1):10.
[7] Contarelli S,Fedele V,Melisi D.HOX genes family and cancer:A novel role for homeobox B9 in the resistance to anti-angiogenic therapies[J].Cancers(Basel), 2020,12(11):3299.
[8] 王 军,欧 理,周清梓,等.直肠癌患者术后血清补体C3、C4水平变化及其与术后疼痛的相关性研究[J].陕西医学杂志,2019,48(8):984-986,996.
[9] Jonkers J,Pai P,Sukumar S.Multiple roles of HOX proteins in metastasis:Let me count the ways[J].Cancer Metastasis Rev,2020,39(3):661-679.
[10] De-Bessa SA,Araújo M,Pereira T,et al.HOX genes function in breast cancer development[J].Biochim Biophys Acta Rev Cancer,2020,1873(2):188358.
[11] Sun X,Hou L,Qiu C,et al.MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer[J].Cell Mol Biol Lett,2021,26(1):20.
[12] Yang F,Liu D,Deng Y,et al.Frequent promoter methylation of HOXD10 in endometrial carcinoma and its pathological significance[J].Oncol Lett,2020,19(5):3602-3608.
[13] Zhang J,Liu S,Zhang D,et al.Homeobox D10,a tumor suppressor,inhibits the proliferation and migration of esophageal squamous cell carcinoma[J].J Cell Biochem,2019,120(8):13717-13725.
[14] Yuan YH,Wang HY,Lai Y,et al.Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway[J].Cell Commun Signal,2019,17(1):9.
[15] Guo Y,Peng Y,Gao D,et al.Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma[J].Clin Epigenetics, 2017,9:116.
[16] Xue M,Fang Y,Sun G,et al.IGFBP3,a transcriptional target of homeobox D10,is correlated with the prognosis of gastric cancer[J].PLoS One,2013,8(12):e81423.
[17] Wang L,Chen S,Xue M,et al.Homeobox D10 gene,a candidate tumor suppressor,is downregulated through promoter hypermethylation and associated with gastric carcinogenesis[J].Mol Med,2012,18(1):389-400.
[18] Luo Q,Shi W,Dou B,et al.XBP1-IGFBP3 signaling pathway promotes NSCLC invasion and metastasis[J].Front Oncol,2021,11:654995.
[19] Chao CC,Lee WF,Yang WH,et al.IGFBP-3 stimulates human osteosarcoma cell migration by upregulating VCAM-1 expression[J].Life Sci, 2021,265:118758.
[20] Huang Y,Chang A,Zhou W,et al.IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma[J].Clin Exp Med,2020,20(4):515-525.
相似文献/References:
[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(7):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(7):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(7):990.
[4]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(7):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[5]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[6]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(7):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(7):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
CAO Weiwei,GUO Xiutian.Research progress of orthotopic transplantation technology for colorectal cancer[J].,2022,51(7):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
[9]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]
[10]李敬楠,白春英,房 芹.赤峰地区结直肠癌相关KRAS和PIK3CA基因多态性及临床意义[J].陕西医学杂志,2022,51(9):1137.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.022]
LI Jingnan,BAI Chunying,FANG Qin.Polymorphisms of KRAS and PIK3CA genes related to colorectal cancer in Chifeng area and their clinical significance[J].,2022,51(7):1137.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.022]